Viewing Study NCT01110018

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2026-02-08 @ 3:38 PM
Study NCT ID: NCT01110018
Status: COMPLETED
Last Update Posted: 2017-06-27
First Post: 2010-04-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: GSK573719 IV Enabling Study
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tolerability View
None COPD View
None Safety View
None Muscarinic receptor (mAChR) antagonist View
None GSK573719 View
None Healthy subjects View
None Pharmacokinetics View
None IV study View